Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Sebastiaan F. Somers"'
Autor:
Joost S. Vermaat, Sebastiaan F. Somers, Liesbeth C. de Wreede, Willem Kraan, Ruben A.L. de Groen, Anne M. R. Schrader, Emile D. Kerver, Cornelis G. Scheepstra, Henriëtte Berenschot, Wendy Deenik, Jurgen Wegman, Rianne Broers, Jan-Paul D. de Boer, Marcel Nijland, Tom van Wezel, Hendrik Veelken, Marcel Spaargaren, Arjen H. Cleven, Marie José Kersten, Steven T. Pals
Publikováno v:
Haematologica, Vol 105, Iss 2 (2020)
The 2016 World Health Organization classification defines diffuse large B-cell lymphoma (DLBCL) subtypes based on Epstein-Barr virus (EBV) infection and oncogenic rearrangements of MYC/BCL2/BCL6 as drivers of lymphomagenesis. A subset of DLBCL, howev
Externí odkaz:
https://doaj.org/article/93ed3bb67e6c40e09d22bd1f61cc4a61
Autor:
Marcel Spaargaren, Marie José Kersten, Liesbeth C. de Wreede, Wendy Deenik, Jan-Paul D. de Boer, Arjen H.G. Cleven, Henriette Berenschot, Marcel Nijland, Emile D. Kerver, Rianne Broers, Jurgen Wegman, Hendrik Veelken, Sebastiaan F Somers, Cornelis G. Scheepstra, Steven T. Pals, Joost S.P. Vermaat, Anne M. R. Schrader, Ruben A.L. de Groen, Tom van Wezel, Willem Kraan
Publikováno v:
Haematologica, 105(2), 424-434. FERRATA STORTI FOUNDATION
Haematologica, 105(2), 424-434. Ferrata Storti Foundation
Haematologica
Haematologica, 105(2), 424-434. Ferrata Storti Foundation
Haematologica
The 2016 World Health Organization classification defines diffuse large B-cell lymphoma (DLBCL) subtypes based on Epstein-Barr virus (EBV) infection and oncogenic rearrangements of MYC/BCL2/BCL6 as drivers of lymphomagenesis. A subset of DLBCL, howev
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e85f18c77e3a33989ef131aa620c26a4
https://research.rug.nl/en/publications/47497d5d-a291-4310-823e-822931123e0c
https://research.rug.nl/en/publications/47497d5d-a291-4310-823e-822931123e0c
Autor:
Hassan Jumaa, Wilma G. M. Kroes, Henrik E. Mei, Palash Chandra Maity, Daniela Steinbrecher, Christian E. Busse, Tamara Bittolo, Ruben A.L. de Groen, Kostas Stamatopoulos, Konstantia Kotta, Rob S Barendse, Nicholas Chiorazzi, Marvyn T. Koning, Valerio Renna, Antonella Nicolò, Eugen Tausch, Eva Gentner-Göbel, Marc Young, Stephan Stilgenbauer, Cornelis A.M. van Bergen, Massimo Degano, Giovanni Del Poeta, Joost S.P. Vermaat, Paolo Ghia, J Tom van Wezel, Antonella Zucchetto, Sebastiaan F Somers, Mayas Bilal, Katharina Imkeller, Valter Gattei, Hendrik Veelken, Moumita Datta, Hedda Wardemann, Christof Schneider, Riccardo Bomben, Tamam Bakchoul, Andrea Nicola Mazzarello, Axel Schulz
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America
Proceedings of the National Academy of Sciences, 117(8), 4320-4327. NATL ACAD SCIENCES
Proceedings of the National Academy of Sciences
Proceedings of the National Academy of Sciences, 117(8), 4320-4327. NATL ACAD SCIENCES
Proceedings of the National Academy of Sciences
Significance CLL is characterized by autonomous B cell receptor (BCR) signaling. CLL subsets are empirically defined by sequence similarities of the BCR heavy chain. However, in the unfavorable subset 2, an acquired mutation (termed R110) in the ligh
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c2d58aad7f4ec5e2f0632d1dda8f40ce
Autor:
Ronald van Eijk, Myrurgia Abdul Hamid, Rein Willemze, Marcel Nijland, Willem Kraan, Anne M. R. Schrader, Steven T. Pals, Eduardus F. M. Posthuma, Wendy Stevens, Michiel van den Brand, Anne-Marie Cleton-Jansen, Patty M. Jansen, Arjan Diepstra, Maarten H. Vermeer, Marie José Kersten, Arjen H.G. Cleven, Bea Tanis, Sebastiaan F Somers, J.Hendrik Veelken, Joost S.P. Vermaat, Daphne de Jong
Publikováno v:
Blood, 131(18), 2086-2089. AMER SOC HEMATOLOGY
Blood, 131(18), 2086-2089. American Society of Hematology
Blood, 131, 2086-2089
Blood, 131, 18, pp. 2086-2089
Schrader, A M R, Jansen, P M, Willemze, R, Vermeer, M H, Cleton-Jansen, A-M, Somers, S F, Veelken, H, van Eijk, R, Kraan, W, Kersten, M J, van den Brand, M, Stevens, W B C, de Jong, D, Hamid, M A, Tanis, B C, Posthuma, E F M, Nijland, M, Diepstra, A, Pals, S T, Cleven, A H G & Vermaat, J S P 2018, ' High prevalence of MYD88 and CD79B mutations in intravascular large B-cell lymphoma ', Blood, vol. 131, no. 18, pp. 2086-2089 . https://doi.org/10.1182/blood-2017-12-822817
Blood, 131(18), 2086-2089. The American Society of Hematology
Blood, 131(18), 2086-2089
Blood, 131(18), 2086-2089. American Society of Hematology
Blood, 131, 2086-2089
Blood, 131, 18, pp. 2086-2089
Schrader, A M R, Jansen, P M, Willemze, R, Vermeer, M H, Cleton-Jansen, A-M, Somers, S F, Veelken, H, van Eijk, R, Kraan, W, Kersten, M J, van den Brand, M, Stevens, W B C, de Jong, D, Hamid, M A, Tanis, B C, Posthuma, E F M, Nijland, M, Diepstra, A, Pals, S T, Cleven, A H G & Vermaat, J S P 2018, ' High prevalence of MYD88 and CD79B mutations in intravascular large B-cell lymphoma ', Blood, vol. 131, no. 18, pp. 2086-2089 . https://doi.org/10.1182/blood-2017-12-822817
Blood, 131(18), 2086-2089. The American Society of Hematology
Blood, 131(18), 2086-2089
TO THE EDITOR: Intravascular large B-cell lymphoma (IVLBCL) is a rare variant of extranodal diffuse large B-cell lymphoma (DLBCL). It is characterized by proliferation of blastic, neoplastic B cells within the lumina of small- or intermediate-sized b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ecb47f64a11449cce0481a8b077f80b5
https://doi.org/10.1182/blood-2017-12-822817
https://doi.org/10.1182/blood-2017-12-822817
Autor:
Anne M R, Schrader, Patty M, Jansen, Rein, Willemze, Maarten H, Vermeer, Anne-Marie, Cleton-Jansen, Sebastiaan F, Somers, Hendrik, Veelken, Ronald, van Eijk, Willem, Kraan, Marie José, Kersten, Michiel, van den Brand, Wendy B C, Stevens, Daphne, de Jong, Myrurgia, Abdul Hamid, Bea C, Tanis, Eduardus F M, Posthuma, Marcel, Nijland, Arjan, Diepstra, Steven T, Pals, Arjen H G, Cleven, Joost S P, Vermaat
Publikováno v:
Blood. 131(18)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::ab134ad4ece84952b2e602ac2a159a3a
https://pubmed.ncbi.nlm.nih.gov/29514783
https://pubmed.ncbi.nlm.nih.gov/29514783